Clinical validation and diagnostic accuracy of (99m)Tc-EDDA/HYNIC-TOC compared to (111)In-DTPA-octreotide in patients with neuroendocrine tumours: the LACOG 0214 study

(99m)Tc-EDDA/HYNIC-TOC is an easily available and cheaper radionuclide that could be used for somatostatin-receptor-based imaging of neuroendocrine tumours (NETs). We aimed to evaluate the diagnostic performance of (99m)Tc-EDDA/HYNIC-TOC compared to(111)In-DTPA-octreotide in patients (pts) with NETs...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriguchi-Jeckel, Cristina M, Madke, Rafael R, Radaelli, Graciane, Viana, Alice, Nabinger, Patrícia, Fernandes, Bruna, Gössling, Gustavo, Berdichevski, Eduardo H, Vilas, Eduardo, Giacomazzi, Juliana, Rocha, Matheus Soares, Borges, João Alfredo, Hoffmann, Elias, Greggio, Samuel, Venturin, Gianina T, Barrios, Carlos H, Zaffaroni, Facundo, Werutsky, Gustavo, da Costa, Jaderson C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393301/
https://www.ncbi.nlm.nih.gov/pubmed/37533941
http://dx.doi.org/10.3332/ecancer.2023.1582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393301/
https://www.ncbi.nlm.nih.gov/pubmed/37533941
http://dx.doi.org/10.3332/ecancer.2023.1582

Ejemplares similares